Ivabradine's clinical applications are evolving based on its mechanism of selectively inhibiting the funny current.
The clinical use of ivabradine has and continues to evolve along channels that are predicated on its mechanism of action. It selectively inhibits the funny current (I
Koruth et al. (Mon,) studied this question.